Skip to main content

Closed

NXL: Nexalin Technology, Inc. Stock Analysis | finqOS

Healthcare · Medical - Devices

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+78.8% / yr

Operating margin-3084.2%

ROIC-294.5%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio4.07×

Nexalin Technology, Inc.

NXLNASDAQ Capital Market·USD·Closed

Nexalin Technology, Inc.

NXLNASDAQ·USD·Closed

$0.34

−1.23%

$0.34

−$0.00 (1.23%)

52W Range

2thpctl

Volume

0.12×avg

Mkt Cap

7.44MUSD

P/E

-0.7TTM

Div Yield

–ann

52W Range

2thpctl

Volume

0.12×avg

Market Cap

7.44MUSD

P/E Ratio

-0.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings